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I will discuss here some work we are doing 
in our laboratory on the measurement of cerebral 
blood flow (CBF). We are using the gamma camera, 
which is connected to a computer, to measure 
regional CBF. We inject 133Xe into the carotid 
artery and, by using multiple probes, measure the 
clearance from multiple regions of the head. The 
adv.antage of the gamma camera is that it has ex-
cellent resolution and has common probe charac-
teristics. It may be thought of in terms of multiple 
probes, although it has a single crystal, and it 
achieves the desirability of multiple regional CBF 
recordings confined essentially to one hemisphere be-
cause of the depth characteristics of the collimation. 
The formula for height-over-area analysis in 
the clearance for fast and slow flow ( or the first and 
second slopes of the curve, Fl and F2) is handled 
by the computer which gives an automatic write-out. 
ln addition, having injected the xenon, which washes 
out fairly rapidly over an interval of 12 minutes, 
we then inject with a nondiffusable isotope, tech-
netium. By use of a different formula, this gives 
us the regional cerebral blood volume, so that in 
the same patient, we have both the regional cerebral 
blood flow and the regional cerebral blood volume 
on the computer write-out. Table 1 is a typical 
record that comes out of the automatic print-out; 
it has the advantage of being rapid, taking place 
while the patient is being examined. It comes out 
objectively with a minimum amount of error, the 
program being highly reliable, and gives you both the 
regional cerebral blood flow (ROI) and the mean 
hemispheric flow (RCBF "H/ A") , which is in good 
agreement with hydrogen clearance using an entirely 
different methodology, as well as the standard 
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deviation. It gives you the fast or so-called gray 
flow (FG), the white flow (FW), the so-called 
weight of gray matter (WG), the weight of white 
matter (WW), a regional flow calculated by an-
other method (RCBF "LOG"), and the regional 
cerebral blood volume (RCBF) , which is of con-
siderable use because, knowing blood flow, blood 
volume, and cerebrospinal fluid pressure, you can 
say a great deal about the amount of blood and 
parenchyma present in the region under study and 
about the various pressure-tissue-flow relationships. 
For our Jl1etabolic studies, we feel that it is less 
traumatic and highly reliable to pass the catheter 
up into the lateral sinus via the brachia! vein; thi.s 
is done under visualization of the fluoroscope in 
the cardiac catheterization laboratory. I say it is 
highly reliable, because one can inject a little dye 
at the time of placement of the catheter, from which 
much can be learned. About 20% of patients have 
abnormalities of the venous system, and there is 
no question that, with the blind puncture or modifi-
catio~s of it, the needle often finishes up sampling 
blood that was certainly not coming from the brain, 
which accounts for some of the errors in methods. 
To summarize some of the data-it will be 
found that the earlier the patient is studied after 
a stroke, the greater is the reduction of CBF. I 
would like to point out that CBF is reduced not 
only on the diseased side but also on the healthy 
side (Table 2). We called it diaschisis and supposed 
that it was due to the release, following stroke, 
bilaterally or perhaps from the brain stem, of some 
neurotransmitter, and it was suggested that it might 
be serotonin or some related substance. Judging 
from pur current studies, it now appears that indeed 
there are neurotransmitter releases in a unilateral 
stroke and that these neurotransmitters, bilaterally, 
include norepinephrine, serotonin, and C-AMP; 
these reduce cerebral blood flow and decrease me-
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TABLE 1 
REGIONAL CEREBRAL BLOOD FLOW MEASUREMENTS USING GAMMA CAMERA 
AND lNTERTECHNIQUE COMPUTER SYSTEM 
Typical Print-Out of RCBF Data 
ROI RCBF"H/A" FG WG FW WW RCBF "LOG" RCBV 
1,4 42.2 41. 57 65.1 14.81 34.9 32.2 9.62 
2,3 35.2 48.93 38.2 28.27 61.8 36.2 8.95 
2,4 33.7 43.88 46.3 19.70 53.7 30.9 7.58 
2,5 32.5 37.52 49.1 18.96 50.9 28.1 6.29 
2,6 32.0 33.69 61.0 16.27 39.0 26.9 6.09 
3,3 32.2 46.13 47 . 8 19.62 52 .2 32.3 8.30 
3,4 32.5 41.98 49.5 17.73 50.5 29.7 6.49 
3,5 27.6 38.04 34. 3 19.81 65.7 26 . 1 5.59 
3,6 26.8 50.74 35.5 25.35 64.5 34.3 5. 21 
4;3 35.4 53.48 30.3 30.26 69.7 37.3 7. 36 
4,4 35.4 52.30 44.3 25.99 55.7 37.6 6 . 37 
4,5 37.1 51. 31 33.0 19.81 67.0 30.2 4.90 
4,6 23.9 31.24 29.9 25 .84 70.1 27.5 4.77 
5,4 26.9 49.68 29.0 23.76 71.0 31. 3 5.59 
5,5 24.6 59.84 10.7 28.68 89.3 32.0 4.50 
6,4 19.4 30.68 25.l 17.24 74.9 20.6 4 .05 
6,5 22.1 33 .82 43.5 40.35 56.5 23 . 2 4.15 
MEAN 30.0 41. 87 39.5 23.08 60.5 30.4 6.22 
S.D. 5.7 13.04 13.0 6.27 13.0 4.6 1. 61 
Radioisotope: 133Xe 
Diagnosis: Acute subarachnoid hemorrhage due to rupture of basilar artery aneurysm, diffuse vasospasm, and acute 
hydrocephalus 
TABLE 2 
HEMISPHERIC BLOOD FLOW AND METABOLIC INDEXES 
IN A SERIES OF PATIENTS WITH ACUTE UNILATERAL CEREBRAL lSCHEMIA 
HBF 
(ml / 100 gm brain / min) 
HMI0 , 
(ml / 100 gm brain/ min) 
HMico, 
(ml / 100 gm brain/min) 
HMio r 
(ml / 100 gm brain/ min) 
HG:O 
(ml / 100 gin brain/ min) 
HRQ 
Values = mean ± standard deviation 
N = number of cases 
P = t test values 
HBF = hemispheric blood flow 
Healthy Side Diseased Side 
34.6 ± 3.4 (N = 30) 32. 4 ± 3.3 (N = 32) 
f-- -----10.01 < p < 0 .02---------< 
2.28 ± 0.42 (N = 25) 2.07 ± 0.45 (N = 31) 
1.84 ± 0.52 (N = 24) 1.88 ± 0.48 (N = 31) 
3.54 ± l.17(N = 25) 2 .87 ± 1.02(N = 30) 
f-- -----10 .02 < p < 0.05---------< 
1. 58 ± 0. 54 (N = 25) 1. 46 ± 0. 63 (N = 30) 
0.80±0.17(N = 24) 0.92±0.23(N = 31) 
1--------10.02 < p < 0 .05---------< 
HMI0 , = hemispheric oxygen consumption 
HMic o, = hemispheric carbon dioxide production 
HMI01 = hemispheric cpnsumption of glucose 
HG:O = hemispheric glucose:oxygen utilization ratio 
HRQ = hemispheric respiratory quotient 
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tabolism bilaterally, despite the fact that one has 
only a unilateral stroke (Fig. 1) . 
One notices that with the passage of time, CBF 
improves and after about three weeks, the flow in 
the nonischemic hemisphere returns to normal. The 
quantitative reduction inflow also correlates with 
the size of the infarct, as assessed clinically, as well 
as with the degree of EEG change, particularly if 
it is a cortical infarct; the correlation is a little more 
difficult if it is a subcortical infarct. There are corre-
lations, to some extent, with other assessments of the 
degree of involvement such as of the brain stem. Bi-
lateral reduction of oxygen and glucose consumption 
and C02 production are noted, as well as blood flow 
reduction, although there is a greater reduction on 
the diseased side than on the healthy side, the respi-
ratory quotient (RQ) is normal. 
It should be noted that a hemisphere having 
a major infarct with hemiplegia still consumes appre-
ciable oxygen-more than one would think, consid-
ering the neurological deficit. Also, abnormal me-
tabolism was occurring on both sides (Table 3). 
There was a release of free fatty acids and inorganic 
phosphate, as well as serotonin and norepinephrine, 
from the infarcted brain; this has now been con-
firmed from cerebrospinal fluid . Inorganic phosphate 
from the infarcted brain appears only in the first 
14 days of stroke and tends, with the recovery 
process, to revert to no essential A-V difference. 
I want to mention a little about studies with 
DIASCHISIS - - -
IMPAIRED 
NEUROTRANSMITTER 
VASCULAR OCCLUSION (ARTERIAL OR VENOUS) 
CARDIAC ARRESl 
AN O XIC ANOXIA 
TRAUMA, TUMOR, elc . 
FUNCTION J \ REOUCEO CEREBRAL 
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ENERGY PRODUCTION 
the use of intravenous glycerol and its effects on 
CBF and metabolism. We are interested in glycerol 
because not only did it bring about a significant 
reduction in intracranial pressure in our stroke 
patients, after intravenous treatment, but the pa-
tients also showed a significant clinical improve-
ment. We were unable to show this with mannitol 
and, for this reason, think that perhaps glycerol 
had some metabolic benefits along with its hyper-
osmolar effect. It is a very nice investigative tool 
for manipulating the cerebral metabolism as well. 
An infusion of glycerol increases cerebral blood 
flow, but ( and this was a big surprise to us) it 
decreases the oxygen consumption. We have 30 
more patients now and this has become highly sig-
nificant. The C02 production also goes down, and 
the glucose consumption (in a mixed group of 
patients) has a tendency to increase, which was 
TABLE 3 
~-Hydroxybutyrate 
(mg/ di) 
Glutamate 
(mg/ di) 
Triglyceride 
(mg/ di) 
H EMISPHERIC METABOLISM IN A CUTE UNILATERAL C EREBRAL fSC HEMIA 
Arterial 
Concentration 
Arteriocerebral Venous Difference 
Healthy Side Diseased Side 
4 . 36±4. 47(N = 13) + I.04±0. 73* (N = 6) +0.27±0.32*(N = 13) 
0 .001 < P < 0 .005,-----! 
3.98 ± 2.21 (N = 9) + 0 . 25 ± 0.25* (N = 7) +0. 21 ± 0 . 15(N = 8) 
87 . 5 ± 38 . 5 (N = 13) + I. 3 ± 10.6 (N = 9) + I.5 ± 7.0 (N = 13) 
1. 153 ± 1.765(N = 8) +0. 121 ± 0.237(N = 5) -0. 208 ± 0 . 217* (N = 8) 
2. 34 ± 0.49 (N = 14) - 0 . 13 ± 0 . 23 (N = 6) -0.15 ± 0 . 12* (N = 14) 
Concentration 
in CSP 
N.E. 
N.E. 
N.E. 
N.E. 
N.E. 
Free Fatty Acid 
(mM/ L) 
Inorganic 
Phosphate 
(mg/ di) 
Serotonin 
(µg/dl) 
12.48 ± 4. 35 (N = 18) l .92 ± 3. 19 (N = 12) - 0 . 23 ± 1.92(N = 18) 6. 10 ± 4 . 86* (N 
>------10.02 < P < 0.05*----...... 
* = statistically significant difference from normal 
Values = mean ± standard deviation 
N = number of cases 
N.E. = not examined 
18) 
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EF FECT OF IV GLYCEROL ON rCBF 
STEADY STATE 
PoCOz . 38 
AFTER 500ml of Glycerol 
PoCOz 36.5 
A CASE OF ACUTE CEREBRAL INFARC TION 
HBF : 33.8 ml/lOOgmlmin 
HBF : 36.8 ml/lOOgm/min 
significant in diabetics and insignificant in non-
diabetics. We have postulated that we were im-
proving metabolism other than the usual oxidative 
metabolism; possibly, we were recoupling uncoupled 
oxidative metabolism. We also considered that 
glycerol may provide another source of energy, which 
may tend to improve cerebral energy production as 
well as the membrane integrity and function. The 
EEG improves regularly and the improvement ap-
pears within two hours during continuous recording. 
There is an increase in central venous pressure, as 
might be anticipated, due to the hyperosmolar effect 
of an infusion of 500 cc of a substance that is 
drawing fluid into the circulating blood volume. Since 
the intracranial venous pressure is a mean between 
the central venous pressure and the cerebrospinal 
fluid (CSF) pressure, then essentially, there is an 
increase followed by a decrease in the intracranial 
venous pressure. The mean arterial pressure is in-
creased also by a substance that increases a cir-
culating blood volume. Regional CBF and blood 
volume studies of the effects of glycerol on the 
ischemic area of the middle cerebral artery occlu-
sion show redistribution of blood with an increase 
in blood flow and blood volume in the infarcted 
zone (Fig. 2). Often, if there is a marked hyperemia 
on the border zone, there is a redistribution of blood 
in the infarcted zone, with reduction on the bordering 
zone. The mean hemispheric flow goes up regularly. 
Our data show a significant reduction, after the use 
of glycerol, in the release of free fatty acids and/ or 
inorganic phosphates from the infarcted brain. We 
believe that glycerol is combining with free fatty 
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acids to form triglycerides. Inorganic phosphate may 
be taken up by ADP to form ATP. It could also 
be that the phospholipids are being resynthesized. 
Norepinephrine and serotonin in the CSF of 
patients with acute stroke are elevated; it seemed 
likely that, in cerebral ischemia, the reduced tissue 
P0 2 might be interfering with the synthesis of 
neurotransmitters, such as norepinephrine and sero-
tonin and that the release of these might interfere 
with neuronal function. We measured C-AMP in 
the cerebrospinal fluid of these patients and found 
that it was significantly increased, actually much 
more significantly than serotonin and norepinephrine. 
If these neurotransmitters were disordered in the 
brain and were causing trouble, we wondered 
whether, with the use of adrenergic blockades such 
as propranolol or phenoxybenzamine, one could 
show an effect similar to that of glycerol, and 
indeed, this is what happened. The introduction of 
propranolol shows the same reduction of oxygen 
consumption, C02 production, and glucose utiliza-
tion. This reaction makes sense because norepineph-
rine is known to stimulate glycolysis and oxidative 
consumption and has been shown to be released 
in infarcted brain and to stimulate the release of 
free fatty acid. This finding supported our view 
that the release of these neurotransmitters is very 
important in cerebral infarction and may enhance 
the symptoms. We found also that the release of 
fatty acids was improved by the infusion of pro-
pranolol, which makes sense because norepinephrine 
stimulates the release of free fatty acids from fat 
stores and lipids. Inorganic phosphate, likewise, 
tended to be reduced and the consumption of tri-
glyceride, increased. Phenoxybenzamine, which is 
another a-adrenergic blocker and blocks serotonin 
as well as norepinephrine without having any effect 
whatsoever on hemispheric blood flow, reduced oxy-
gen consumption and C02 production in the same 
pattern that we found with both propranolol and 
glycerol. The use of phenoxybenzamine tended to 
reduce the release of free fatty acids and enhance 
the uptake of inorganic phosphate and triglycerides 
by the brain. 
After about the 14th day, the serotonin dis-
appears, as does the C-AMP, from the cerebrospinal 
fluid in patients with acute cerebral infarction; the 
serotonin change can be correlated with the cerebral 
blood flow. As the serotonin disappears, CBF in-
creases, which supports the view that serotonin is 
important in diaschisis and the bilateral reduction 
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of CBF. Other vasoconstrictive substances, such as 
epinephrine or norepinephrine, angiotensin, or 
prostaglandins may exist, which we have not mea-
sured yet. 
C-AMP is the second messenger for virtually 
all the neurotransmitters of the central nervous sys-
tem, certainly for serotonin and norepinephrine. 
We found that there was similar elevation of C-
AMP in cerebral venous blood when compared 
to the arterial blood in the steady state before 
glycerol. After giving glycerol, there was a reduc-
tion in the cerebral venous C-AMP, an inhibition of 
the release of C-AMP from the infarcted brain. 
An elevation of C-AMP in the steady state was 
noted in the cerebrospinal fluid of patients with 
cerebral infarction as well. When glycerol is given 
intravenously, there is a reduction of the C-AMP 
in the cerebrospinal fluid. 
This consideration of the relationship of neuro-
transmitters not only to cerebral infarction but also 
to subarachnoid hemorrhage is, to my mind, the 
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most promising area of investigation over the next 
decade. There is also a quantity of evidence that 
neurotransmitters play a large part in spasm fol-
lowing subarachnoid hemorrhage and in the dis-
turbance of neurological function in that situation. 
Following subarachnoid hemorrhage, some remedi-
able medical problems arise. Apart from clipping 
of the aneurysm, which the neurosurgeons are able 
to do, there is the problem of communicating hydro-
cephalus, which is extremely common in about 
40% of patients. It can be discerned by the method 
of determining regional CBF and doing a spinal 
tap. If you note an increase in cerebral blood flow 
with removal of 25 cc of spinal fluid, you know 
you have a problem with communicating hydro-
cephalus. This is because autoregulation is disturbed. 
This increase will not occur when a spinal tap is 
done on a normal person who does not have com-
municating hydrocephalus. Finally, one can give 
glycerol and reduce the brain edema in patients 
with subarachnoid hemorrhage and brain swelling. 
